CD147 - Network of Cancer Research

SP-8356 is a Potent and Orally Active CD147 Inhibitor

Breast cancer is one of the most fatal diseases in women and exhibits high incidence and mortality among various cancers. Among various signaling pathways that promote tumor growth and progression,…

Liver Cancer

AC-73 is a Specific and Orally Active CD147 Dimerization Inhibitor

Louis Gilman November 24, 2019

Hepatocellular carcinoma (HCC) is one of the most common cancers. Combating hepatocellular carcinoma invasion and metastasis has become a major desire in hepatocellular carcinoma patients. CD147 (also called EMMPRIN) is…

Cancer

SP-8356 is a Potent and Orally Active CD147 Inhibitor

AC-73 is a Specific and Orally Active CD147 Dimerization Inhibitor

You Missed

Irinotecan is a Topoisomerase I Inhibitor for Colorectal Cancer Research

Copanlisib is a Pan-class I PI3K Inhibitor for Lymphoma Resaerch

Erlotinib is an EGFR TKI for NSCLC and Pancreatic Cancer Research

Parsaclisib is an Orally Active PI3Kδ Inhibitor for B-cell Malignancies Research